{"timestamp": 1771602956.364567, "value": {"ticker": "ABUS", "company_name": "Arbutus Biopharma Corporation", "short_name": "Arbutus Biopharma Corporation", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 831801344, "float_shares": 124529801, "shares_outstanding": 192324017, "short_ratio": 8.95, "short_percent_of_float": 0.1, "shares_short": 13558940, "shares_short_prior": 12535638, "insider_percent_held": 0.21802999, "institution_percent_held": 0.64561, "total_cash": 93702000, "total_debt": 4606000, "total_revenue": 14606000, "revenue_growth": -0.605, "earnings_growth": 0, "profit_margins": -2.8945, "gross_margins": -0.98857003, "operating_margins": -15.67675, "debt_to_equity": 5.951, "current_ratio": 18.797, "book_value": 0.403, "price_to_book": 10.73201, "operating_cashflow": -45272000, "free_cashflow": -24302000, "price": 4.325, "52w_high": 5.1, "52w_low": 2.71, "avg_volume": 1521958, "avg_volume_10d": 2379020, "full_time_employees": 44, "audit_risk": 4, "overall_risk": 7}}